-
- Erratum in:
- N Engl J Med 1990 Jan 25;322(4):280.
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides.
Clinical Oncology Program, National Cancer Institute, Bethesda, MD 20892.
PMID: 2671731 [PubMed - indexed for MEDLINE]
-
Related articles
-
The antiretroviral and cytostatic activity, and metabolism of 3'-azido-2',3'-dideoxythymidine, 3'-fluoro-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly cell type-dependent.
Adv Exp Med Biol. 1989; 253B:407-13.
[Adv Exp Med Biol. 1989]
-
ReviewClinical applications of 3'-azido-2',3'-dideoxythymidine (AZT) and related dideoxynucleosides.
Med Res Rev. 1990 Oct-Dec; 10(4):419-39.
[Med Res Rev. 1990]
-
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
J Exp Med. 1988 Sep 1; 168(3):1111-25.
[J Exp Med. 1988]
-
5-Chloro-substituted derivatives of 2', 3'-didehydro-2',3'-dideoxyuridine, 3'-fluoro-2',3'-dideoxyuridine and 3'-azido-2',3'-dideoxyuridine as anti-HIV agents.
Biochem Pharmacol. 1989 Mar 15; 38(6):869-74.
[Biochem Pharmacol. 1989]
-
ReviewHIV drug resistance.
AIDS Res Hum Retroviruses. 1992 Jun; 8(6):1065-71.
[AIDS Res Hum Retroviruses. 1992]
- » See reviews... | » See all...
Cited by 35 PubMed Central articles
-
Pharmacokinetic interaction between zidovudine and trimethoprim/sulphamethoxazole in HIV-1 infected children.
Dallas S, E Read S, King S, Koren G, Bendayan R.
Can J Infect Dis. 2000 Sep; 11(5):254-8.
[Can J Infect Dis. 2000]
-
Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study.
McDowell JA, Chittick GE, Ravitch JR, Polk RE, Kerkering TM, Stein DS.
Antimicrob Agents Chemother. 1999 Dec; 43(12):2855-61.
[Antimicrob Agents Chemother. 1999]
-
Mechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants.
Gu Z, Wainberg MA, Nguyen-Ba N, L'Heureux L, de Muys JM, Bowlin TL, Rando RF.
Antimicrob Agents Chemother. 1999 Oct; 43(10):2376-82.
[Antimicrob Agents Chemother. 1999]
- » See all...